Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | GSK3B | P49841 | 1/20 | 0.42 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.42 |
| ▸ | NAMPT | P43490 | 2/20 | 0.40 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.40 |
| ▸ | BCL2 | P10415 | 1/20 | 0.39 |
| ▸ | DEGS1 | O15121 | 2/20 | 0.39 |
| ▸ | ATR | Q13535 | 1/20 | 0.39 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | METAP1 | P53582 | 1/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.36 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2197407 | 0.84 | HDAC1 (0.41) | HDAC1GSK3BDYRK1ANAMPTGRIN2B | |
| SCHEMBL6609814 | 0.79 | NAMPT (0.52) | HDAC1GSK3BDYRK1ANAMPTBCL2 | |
| SCHEMBL851343 | 0.79 | DEGS1 (0.56) | GSK3BDYRK1ANAMPTGRIN2BDEGS1 | |
| SCHEMBL1126145 | 0.79 | RAB9A (0.62) | GSK3BDYRK1AMAPTRAB9A | |
| SCHEMBL22606745 | 0.78 | DEGS1 (0.48) | HDAC1GSK3BDYRK1ANAMPTGRIN2B | |
| SCHEMBL30506468 | 0.78 | DEGS1 (0.48) | HDAC1GSK3BDYRK1ANAMPTGRIN2B | |
| SCHEMBL283737 | 0.78 | RAB9A (0.51) | BCL2MAPTRAB9A | |
| SCHEMBL56219 | 0.78 | PTGS1 (0.50) | HDAC1GSK3BDYRK1ANAMPTGRIN2B | |
| SCHEMBL12461458 | 0.78 | GSK3B (0.44) | HDAC1GSK3BDYRK1ANAMPTGRIN2B | |
| SCHEMBL4398253 | 0.78 | GSK3B (0.44) | HDAC1GSK3BDYRK1ANAMPTGRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4605392-A1 | METHODS FOR TREATING CANCER | Antares Therapeutics, Inc. (US) | 2025-08-27 | — | — | EP | disclosed |
| WO-2024086809-A1 | METHODS FOR TREATING CANCER | SCORPION THERAPEUTICS, INC. (US) | 2024-04-25 | — | — | WO | disclosed |